These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 29352500)

  • 1. Characterization of skin blister fluids from children with Epstein-Barr virus-associated lymphoproliferative disease.
    Wada T; Toma T; Miyazawa H; Koizumi E; Shirahashi T; Matsuda Y; Yachie A
    J Dermatol; 2018 Apr; 45(4):444-449. PubMed ID: 29352500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atypical hydroa vacciniforme-like epstein-barr virus associated T/NK-cell lymphoproliferative disorder.
    Lee HY; Baek JO; Lee JR; Park SH; Jeon IS; Roh JY
    Am J Dermatopathol; 2012 Dec; 34(8):e119-24. PubMed ID: 23169419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenic link between hydroa vacciniforme and Epstein-Barr virus-associated hematologic disorders.
    Iwatsuki K; Satoh M; Yamamoto T; Oono T; Morizane S; Ohtsuka M; Xu ZG; Suzuki D; Tsuji K
    Arch Dermatol; 2006 May; 142(5):587-95. PubMed ID: 16702496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydroa vacciniforme: a distinctive form of Epstein-Barr virus-associated T-cell lymphoproliferative disorders.
    Iwatsuki K; Miyake T; Hirai Y; Yamamoto T
    Eur J Dermatol; 2019 Feb; 29(1):21-28. PubMed ID: 30998212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological states of Epstein-Barr virus-associated T/NK-cell lymphoproliferative disorders (severe chronic active EBV infection) of children and young adults.
    Suzuki K; Ohshima K; Karube K; Suzumiya J; Ohga S; Ishihara S; Tamura K; Kikuchi M
    Int J Oncol; 2004 May; 24(5):1165-74. PubMed ID: 15067338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus reactivation is induced, but abortive, in cutaneous lesions of systemic hydroa vacciniforme and hypersensitivity to mosquito bites.
    Yamamoto T; Hirai Y; Miyake T; Hamada T; Yamasaki O; Morizane S; Fujimoto W; Iwatsuki K
    J Dermatol Sci; 2016 Jun; 82(3):153-9. PubMed ID: 27039668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydroa vacciniforme is associated with increased numbers of Epstein-Barr virus-infected γδT cells.
    Hirai Y; Yamamoto T; Kimura H; Ito Y; Tsuji K; Miyake T; Morizane S; Suzuki D; Fujii K; Iwatsuki K
    J Invest Dermatol; 2012 May; 132(5):1401-8. PubMed ID: 22297643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical and pathological features of 13 children with Epstein-Barr virus-positive lymphoproliferative disease].
    Chen TM; Deng ZJ; Hu B; Hu HL; Chen HY; Li SY; Liu G
    Zhonghua Er Ke Za Zhi; 2018 Oct; 56(10):759-764. PubMed ID: 30293280
    [No Abstract]   [Full Text] [Related]  

  • 9. Characterization of Epstein-Barr virus (EBV)-positive NK cells isolated from hydroa vacciniforme-like eruptions.
    Demachi A; Nagata H; Morio T; Oyoshi MK; Zhang Y; Tabata N; Kimura N; Shimizu N; Yamamoto K
    Microbiol Immunol; 2003; 47(7):543-52. PubMed ID: 12953848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydroa vacciniforme-like Epstein-Barr virus-associated monoclonal T-lymphoproliferative disorder in a child.
    Wu YH; Chen HC; Hsiao PF; Tu MI; Lin YC; Wang TY
    Int J Dermatol; 2007 Oct; 46(10):1081-6. PubMed ID: 17910721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Delayed diagnosis of hydroa vacciniforme-like lymphoproliferative disorder in a patient with skin rashes].
    Umeki Y; Ikeda M; Nakahara W; Asako M; Matsuoka Y; Terakawa T; Matsunaga H; Tadokoro R; Sekiguchi M; Matsui T; Oka K; Higuchi K; Sawada A; Inoue M; Ueda S
    Rinsho Ketsueki; 2023; 64(3):209-213. PubMed ID: 37019675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant expression of NK cell receptors in Epstein-Barr virus-positive gammadelta T-cell lymphoproliferative disorders.
    Zhang Y; Ohyashiki JH; Shimizu N; Ohyashiki K
    Hematology; 2010 Feb; 15(1):43-7. PubMed ID: 20132662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival rates and prognostic factors of Epstein-Barr virus-associated hydroa vacciniforme and hypersensitivity to mosquito bites.
    Miyake T; Yamamoto T; Hirai Y; Otsuka M; Hamada T; Tsuji K; Morizane S; Suzuki D; Aoyama Y; Iwatsuki K
    Br J Dermatol; 2015 Jan; 172(1):56-63. PubMed ID: 25234411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proposed categorization of pathological states of EBV-associated T/natural killer-cell lymphoproliferative disorder (LPD) in children and young adults: overlap with chronic active EBV infection and infantile fulminant EBV T-LPD.
    Ohshima K; Kimura H; Yoshino T; Kim CW; Ko YH; Lee SS; Peh SC; Chan JK;
    Pathol Int; 2008 Apr; 58(4):209-17. PubMed ID: 18324913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unrelated bone marrow transplantation for Epstein-Barr virus-associated T/NK-cell lymphoproliferative disease.
    Okamura T; Kishimoto T; Inoue M; Honda M; Yamashita N; Wakiguchi H; Yagita M; Hosoi G; Sako M; Yasui M; Yagi K; Kawa K
    Bone Marrow Transplant; 2003 Jan; 31(2):105-11. PubMed ID: 12621491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological categorization of hydroa vacciniforme-like lymphoproliferative disorder: an analysis of prognostic implications and treatment based on 19 cases.
    Guo N; Chen Y; Wang Y; Huang Y; Feng Y; Li M; Rao H
    Diagn Pathol; 2019 Jul; 14(1):82. PubMed ID: 31315684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clonal origin of Epstein-Barr virus (EBV)-infected T/NK-cell subpopulations in EBV-positive T/NK-cell lymphoproliferative disorders of childhood.
    Ohga S; Ishimura M; Yoshimoto G; Miyamoto T; Takada H; Tanaka T; Ohshima K; Ogawa Y; Imadome K; Abe Y; Akashi K; Hara T
    J Clin Virol; 2011 May; 51(1):31-7. PubMed ID: 21377409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus-positive cytotoxic T-cell lymphoma followed by chronic active Epstein-Barr virus infection-associated T/NK-cell lymphoproliferative disorder: a case report.
    Kato S; Miyata T; Takata K; Shimada S; Ito Y; Tomita A; Elsayed AA; Takahashi E; Asano N; Kinoshita T; Kimura H; Nakamura S
    Hum Pathol; 2013 Dec; 44(12):2849-52. PubMed ID: 24012167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An adult case of systemic Epstein-Barr virus-positive T/natural killer-cell lymphoproliferative disorder with good outcome.
    Zhang X; Wang Z; Wang L; Yao H
    Int J Clin Exp Pathol; 2013; 6(11):2620-4. PubMed ID: 24228130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acquired hemophilia A associated with Epstein-Barr-virus-associated T/natural killer-cell lymphoproliferative disease: A case report.
    Yamamoto M; Shindo M; Sumi C; Igarashi S; Saito T; Tsukada N; Toki Y; Hatayama M; Inamura J; Sato K; Mizukami Y; Torimoto Y; Okumura T
    Medicine (Baltimore); 2021 Apr; 100(16):e25518. PubMed ID: 33879690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.